Literature DB >> 4942959

A controlled study of lithium vs. chlorpromazine in acute schizophrenics.

B Shopsin, S S Kim, S Gershon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4942959     DOI: 10.1192/bjp.119.551.435

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


× No keyword cloud information.
  7 in total

1.  The differential effect of lithium on noradrenaline- and dopamine-sensitive accumulation of cyclic AMP in guinea pig brain.

Authors:  A Reches; R P Ebstein; R H Belmaker
Journal:  Psychopharmacology (Berl)       Date:  1978-07-06       Impact factor: 4.530

2.  Efficacy of lithium in schizophrenia.

Authors:  S Dube; B B Sethi
Journal:  Indian J Psychiatry       Date:  1981-07       Impact factor: 1.759

3.  Lithium and chlorpromazine: a controlled crossover study of hyperactive severely disturbed young children.

Authors:  M Campbell; B Fish; J Korein; T Shapiro; P Collins; C Koh
Journal:  J Autism Child Schizophr       Date:  1972 Jul-Sep

4.  Association of Polygenic Score for Schizophrenia and HLA Antigen and Inflammation Genes With Response to Lithium in Bipolar Affective Disorder: A Genome-Wide Association Study.

Authors:  Azmeraw T Amare; Klaus Oliver Schubert; Liping Hou; Scott R Clark; Sergi Papiol; Urs Heilbronner; Franziska Degenhardt; Fasil Tekola-Ayele; Yi-Hsiang Hsu; Tatyana Shekhtman; Mazda Adli; Nirmala Akula; Kazufumi Akiyama; Raffaella Ardau; Bárbara Arias; Jean-Michel Aubry; Lena Backlund; Abesh Kumar Bhattacharjee; Frank Bellivier; Antonio Benabarre; Susanne Bengesser; Joanna M Biernacka; Armin Birner; Clara Brichant-Petitjean; Pablo Cervantes; Hsi-Chung Chen; Caterina Chillotti; Sven Cichon; Cristiana Cruceanu; Piotr M Czerski; Nina Dalkner; Alexandre Dayer; Maria Del Zompo; J Raymond DePaulo; Bruno Étain; Peter Falkai; Andreas J Forstner; Louise Frisen; Mark A Frye; Janice M Fullerton; Sébastien Gard; Julie S Garnham; Fernando S Goes; Maria Grigoroiu-Serbanescu; Paul Grof; Ryota Hashimoto; Joanna Hauser; Stefan Herms; Per Hoffmann; Andrea Hofmann; Stephane Jamain; Esther Jiménez; Jean-Pierre Kahn; Layla Kassem; Po-Hsiu Kuo; Tadafumi Kato; John Kelsoe; Sarah Kittel-Schneider; Sebastian Kliwicki; Barbara König; Ichiro Kusumi; Gonzalo Laje; Mikael Landén; Catharina Lavebratt; Marion Leboyer; Susan G Leckband; Alfonso Tortorella; Mirko Manchia; Lina Martinsson; Michael J McCarthy; Susan McElroy; Francesc Colom; Marina Mitjans; Francis M Mondimore; Palmiero Monteleone; Caroline M Nievergelt; Markus M Nöthen; Tomas Novák; Claire O'Donovan; Norio Ozaki; Urban Ösby; Andrea Pfennig; James B Potash; Andreas Reif; Eva Reininghaus; Guy A Rouleau; Janusz K Rybakowski; Martin Schalling; Peter R Schofield; Barbara W Schweizer; Giovanni Severino; Paul D Shilling; Katzutaka Shimoda; Christian Simhandl; Claire M Slaney; Alessio Squassina; Thomas Stamm; Pavla Stopkova; Mario Maj; Gustavo Turecki; Eduard Vieta; Julia Volkert; Stephanie Witt; Adam Wright; Peter P Zandi; Philip B Mitchell; Michael Bauer; Martin Alda; Marcella Rietschel; Francis J McMahon; Thomas G Schulze; Bernhard T Baune
Journal:  JAMA Psychiatry       Date:  2018-01-01       Impact factor: 21.596

5.  Pharmacokinetics of lithium: elimination half-time, renal clearance and apparent volume of distribution in schizophrenia.

Authors:  R W Mason; E G McQueen; P J Keary; N M James
Journal:  Clin Pharmacokinet       Date:  1978 May-Jun       Impact factor: 6.447

6.  The effect of haloperidol on epinephrine-stimulated adenylate cyclase in humans.

Authors:  R H Belmaker; R P Ebstein; H Schoenfeld; R Rimon
Journal:  Psychopharmacology (Berl)       Date:  1976-09-17       Impact factor: 4.530

Review 7.  Lithium for schizophrenia.

Authors:  Stefan Leucht; Bartosz Helfer; Markus Dold; Werner Kissling; John J McGrath
Journal:  Cochrane Database Syst Rev       Date:  2015-10-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.